| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - paraffin section; human; 1:200; fig 2
| Mannhardt I, Breckwoldt K, Letuffe Brenière D, Schaaf S, Schulz H, Neuber C, et al. Human Engineered Heart Tissue: Analysis of Contractile Force. Stem Cell Reports. 2016;7:29-42 pubmed publisher |
- immunocytochemistry; mouse; fig s2
| Yamakawa H, Muraoka N, Miyamoto K, Sadahiro T, Isomi M, Haginiwa S, et al. Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions. Stem Cell Reports. 2015;5:1128-1142 pubmed publisher |
- immunocytochemistry; human; 1:50; fig s10
| Birket M, Ribeiro M, Verkerk A, Ward D, Leitoguinho A, Den Hartogh S, et al. Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells. Nat Biotechnol. 2015;33:970-9 pubmed publisher |
| Amrute Nayak M, Nayak A, Steffen W, Tsiavaliaris G, Scholz T, Brenner B. Transformation of the Nonprocessive Fast Skeletal Myosin II into a Processive Motor. Small. 2019;15:e1804313 pubmed publisher |
| Krause J, Löser A, Lemoine M, Christ T, Scherschel K, Meyer C, et al. Rat atrial engineered heart tissue: a new in vitro model to study atrial biology. Basic Res Cardiol. 2018;113:41 pubmed publisher |
| Edwards S, Zlochiver V, Conrad D, Vaidyanathan R, Valiquette A, Joshi Mukherjee R. A Multiwell Cardiac ?GMEA Platform for Action Potential Recordings from Human iPSC-Derived Cardiomyocyte Constructs. Stem Cell Reports. 2018;11:522-536 pubmed publisher |
| Ghazizadeh Z, Fattahi F, Mirzaei M, Bayersaikhan D, Lee J, Chae S, et al. Prospective Isolation of ISL1+ Cardiac Progenitors from Human ESCs for Myocardial Infarction Therapy. Stem Cell Reports. 2018;10:848-859 pubmed publisher |
| Baljinnyam E, Venkatesh S, Gordan R, Mareedu S, Zhang J, Xie L, et al. Effect of densely ionizing radiation on cardiomyocyte differentiation from human-induced pluripotent stem cells. Physiol Rep. 2017;5: pubmed publisher |
| Wiencierz A, Kernbach M, Ecklebe J, Monnerat G, Tomiuk S, Raulf A, et al. Differential Expression Levels of Integrin α6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes. PLoS ONE. 2015;10:e0143538 pubmed publisher |
| Dorn T, Goedel A, Lam J, Haas J, Tian Q, Herrmann F, et al. Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity. Stem Cells. 2015;33:1113-29 pubmed publisher |
| Mehta A, Ramachandra C, Sequiera G, Sudibyo Y, Nandihalli M, Yong P, et al. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochim Biophys Acta. 2014;1843:2394-402 pubmed publisher |
| Iglesias GarcÃa O, Pelacho B, Prósper F. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. J Mol Cell Cardiol. 2013;62:43-50 pubmed publisher |
| Jung C, Moretti A, Mederos y Schnitzler M, Iop L, Storch U, Bellin M, et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med. 2012;4:180-91 pubmed publisher |
| Herrmann F, Bundschu K, Kühl S, Kuhl M. Tbx5 overexpression favors a first heart field lineage in murine embryonic stem cells and in Xenopus laevis embryos. Dev Dyn. 2011;240:2634-45 pubmed publisher |
| Elliott D, Braam S, Koutsis K, Ng E, Jenny R, Lagerqvist E, et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat Methods. 2011;8:1037-40 pubmed publisher |
| Clements R, Feng J, Cordeiro B, Bianchi C, Sellke F. p38 MAPK-dependent small HSP27 and ?B-crystallin phosphorylation in regulation of myocardial function following cardioplegic arrest. Am J Physiol Heart Circ Physiol. 2011;300:H1669-77 pubmed publisher |
| Behfar A, Yamada S, Crespo Diaz R, Nesbitt J, Rowe L, Perez Terzic C, et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010;56:721-34 pubmed publisher |
| Martinez Fernandez A, Nelson T, Ikeda Y, Terzic A. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. J Cardiovasc Transl Res. 2010;3:13-23 pubmed publisher |
| Van Laake L, Passier R, Monshouwer Kloots J, Verkleij A, Lips D, Freund C, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007;1:9-24 pubmed publisher |
| Rust W, Balakrishnan T, Zweigerdt R. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med. 2009;4:225-37 pubmed publisher |
| Ten Hove M, Makinen K, Sebag Montefiore L, Hunyor I, Fischer A, Wallis J, et al. Creatine uptake in mouse hearts with genetically altered creatine levels. J Mol Cell Cardiol. 2008;45:453-9 pubmed publisher |
| Larsen K, Lygren B, Sjaastad I, Krobert K, Arnkvaern K, Florholmen G, et al. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovasc Res. 2008;80:47-54 pubmed publisher |
| Xu X, Zweigerdt R, Soo S, Ngoh Z, Tham S, Wang S, et al. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy. 2008;10:376-89 pubmed publisher |
| Mummery C, van der Heyden M, De Boer T, Passier R, Ward D, van den Brink S, et al. Cardiomyocytes from human and mouse embryonic stem cells. Methods Mol Med. 2007;140:249-72 pubmed |
